The natural killer cells (CD56+) and B-lymphocytes (CD19+) were present in a relatively small amount only in patients with sSS (9% and 9%, respectively) and sSS/RA (8.7% and 2.2%, respectively). This evidence concerns the gene NCAM1 and rheumatoid arthritis.